FR2512343A1 - Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition - Google Patents

Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition Download PDF

Info

Publication number
FR2512343A1
FR2512343A1 FR8215043A FR8215043A FR2512343A1 FR 2512343 A1 FR2512343 A1 FR 2512343A1 FR 8215043 A FR8215043 A FR 8215043A FR 8215043 A FR8215043 A FR 8215043A FR 2512343 A1 FR2512343 A1 FR 2512343A1
Authority
FR
France
Prior art keywords
methyl
triazole
methanol
amino
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8215043A
Other languages
English (en)
French (fr)
Inventor
Roy Thomas Brittain
Barry John Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2512343A1 publication Critical patent/FR2512343A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8215043A 1981-09-04 1982-09-03 Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition Withdrawn FR2512343A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04

Publications (1)

Publication Number Publication Date
FR2512343A1 true FR2512343A1 (fr) 1983-03-11

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8215043A Withdrawn FR2512343A1 (fr) 1981-09-04 1982-09-03 Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition

Country Status (18)

Country Link
JP (1) JPS5855421A (fi)
KR (1) KR840001276A (fi)
AU (1) AU8799882A (fi)
BE (1) BE894286A (fi)
DE (1) DE3232831A1 (fi)
DK (1) DK396582A (fi)
FI (1) FI823041L (fi)
FR (1) FR2512343A1 (fi)
GB (1) GB2105588B (fi)
GR (1) GR76433B (fi)
IL (1) IL66709A0 (fi)
IT (1) IT8249072A0 (fi)
LU (1) LU84364A1 (fi)
NL (1) NL8203456A (fi)
PT (1) PT75504A (fi)
SE (1) SE8205035L (fi)
ZA (1) ZA826479B (fi)
ZW (1) ZW18582A1 (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627985A1 (fr) * 1988-03-04 1989-09-08 Glaxo Group Ltd Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
CN102238964B (zh) * 2008-12-04 2014-08-06 21世纪国际新技术株式会社 NSAIDs诱因消化道粘膜损伤抑制剂及其制造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016565A1 (en) * 1979-03-02 1980-10-01 Glaxo Group Limited 1,2,4-Triazole derivatives, processes for their production and pharmaceutical compositions containing them
EP0028483A1 (en) * 1979-10-22 1981-05-13 Glaxo Group Limited 1,2,4-Triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016565A1 (en) * 1979-03-02 1980-10-01 Glaxo Group Limited 1,2,4-Triazole derivatives, processes for their production and pharmaceutical compositions containing them
EP0028483A1 (en) * 1979-10-22 1981-05-13 Glaxo Group Limited 1,2,4-Triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627985A1 (fr) * 1988-03-04 1989-09-08 Glaxo Group Ltd Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables
BE1002256A3 (fr) * 1988-03-04 1990-11-06 Glaxo Group Ltd Medicaments.

Also Published As

Publication number Publication date
GB2105588B (en) 1984-07-18
GR76433B (fi) 1984-08-10
IT8249072A0 (it) 1982-09-03
LU84364A1 (fr) 1984-04-24
SE8205035D0 (sv) 1982-09-03
DK396582A (da) 1983-03-05
GB2105588A (en) 1983-03-30
IL66709A0 (en) 1982-12-31
ZA826479B (en) 1984-04-25
AU8799882A (en) 1983-03-10
PT75504A (en) 1982-10-01
FI823041A0 (fi) 1982-09-03
FI823041L (fi) 1983-03-05
DE3232831A1 (de) 1983-03-24
ZW18582A1 (en) 1984-03-28
KR840001276A (ko) 1984-04-30
JPS5855421A (ja) 1983-04-01
BE894286A (fr) 1983-03-02
NL8203456A (nl) 1983-04-05
SE8205035L (sv) 1983-03-05

Similar Documents

Publication Publication Date Title
BE1005086A5 (fr) Compositions pour l'administration buccale.
BE1007268A3 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
FR2613934A1 (fr) Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl) methyl)-4h-carbazol-4-one et de la ranitidine, son procede de fabrication, l'utilisation de ses deux principes actifs pour la fabrication d'un medicament
WO2002083105A2 (en) Composition for enhanced absorption of nsaids
FR2518409A1 (fr) Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose
FR2636532A1 (fr) Compositions pharmaceutiques
CH679011A5 (fi)
GB2105193A (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE1011837A5 (fr) Nouvelle composition de balsalazide.
BE1005115A5 (fr) Compositions pharmaceutiques contenant des derives de furanne.
FR2904774A1 (fr) Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent.
WO2003082256A2 (fr) Traitement des dysfonctionnements sexuels a l'aide d'un antagoniste des recepteurs aux cannabinoides cb1
FR2512343A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition
BE897058A (fr) Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
CH679553A5 (fi)
CA1307739C (en) Anti-inflammatory compositions
FR2512342A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
JPH0296525A (ja) 医薬
FR2627985A1 (fr) Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables
LU85242A1 (fr) Nouvelle association medicamenteuse
JPWO2004017954A1 (ja) ジクロフェナクの副作用軽減剤
FR2584604A1 (fr) Composition therapeutique constituant une nouvelle forme galenique orale pour ameliorer la cinetique de la biodisponibilite
FR2861299A1 (fr) Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
FR2792834A1 (fr) Utilisation du sr 49059, de ses solvats et/ou hydrates pharmaceutiquement acceptables, pour la preparation de medicaments utiles dans le traitement ou la prevention du phenomene de raynaud
BE844773A (fr) Compositions heterocycliques anti-inflammatoires

Legal Events

Date Code Title Description
ST Notification of lapse